In this episode of Updates in Anesthesiology, Dr. Hadzic breaks down the latest evidence comparing ketamine, etomidate, and propofol for tracheal intubation in critically ill patients. Drawing from a 2025 review in Critical Care Medicine, we explore why ketamine is emerging as the safest and most reliable option, while etomidate shows a potential mortality risk, and propofol continues to raise red flags for cardiovascular instability. Get the evidence, the implications, and the practical takeaways, all in one focused episode.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

--------------------------------------------------------- ⁠⁠

#nysora⁠⁠ ⁠⁠#regionalanesthesia⁠⁠ ⁠⁠#anesthesia⁠⁠

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

Ketamine vs. The Rest: Choosing the Safest Induction Agent in Critical Care

Anesthesia Updates